Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
about
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphomaPredicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomabTreatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trial.Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapyStudy of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan.90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy.Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaManaging lymphoma with non-FDG radiotracers: current clinical and preclinical applications.131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.RadNuc: a graphical user interface to deliver dose rate patterns encountered in nuclear medicine with a 137Cs irradiator.Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.Bulky pulmonary mucosa-associated lymphoid tissue lymphoma treated with yttrium-90 ibritumomab tiuxetan.Comparison of TOF-PET and Bremsstrahlung SPECT Images of Yttrium-90: A Monte Carlo Simulation Study.
P2860
Q24633710-3CACDC9D-42E2-4A69-B088-828A6BB69C87Q33392939-E6AAE15F-B475-4AD2-B5AF-09F85F917D4AQ33395088-88EAC5F7-6ECB-44F4-AE66-D3F486527492Q33690729-A6BC36E8-9EED-4819-AEC2-7B3562BED5D7Q33768719-B421A7AF-C3C3-4085-A6AD-67D9E535732AQ34117144-8D78D2A4-66CB-4EFD-B776-F65BA64AE065Q34216815-E9C30C65-5CDB-434A-B818-98C467D980E1Q34255798-69DAFC6F-C60E-4DB9-902B-11D97737F4BCQ34335207-6B33EFB8-13D5-4711-8F2A-13BE456ADDDBQ36426877-CF444020-86DB-45D9-B930-F08CD954B547Q36614459-6B346FBD-C3D9-4164-A591-625177533B92Q36948431-2866CF7C-E38A-444B-A9E4-C74349D3D62CQ36987727-E9744CB2-9351-44CC-9A18-3B704CA5ADE7Q37158273-ABA428AD-9C79-46D7-9151-30ABDAD3FF04Q37343831-C417C021-9F78-4A5C-8382-7B87EBD8CE35Q37824258-DB5D3817-0B74-4964-8B50-E2FBB518CF32Q38364462-EEDB247B-6F01-475C-B328-6BBC1C3A283FQ41962813-92977BC8-9157-477A-AC88-7D71EDDA51F4Q49220668-5EBBC548-3FAB-48D5-B806-546473EFCD63
P2860
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Radiation dosimetry results an ...... d data from 4 clinical trials.
@ast
Radiation dosimetry results an ...... d data from 4 clinical trials.
@en
type
label
Radiation dosimetry results an ...... d data from 4 clinical trials.
@ast
Radiation dosimetry results an ...... d data from 4 clinical trials.
@en
prefLabel
Radiation dosimetry results an ...... d data from 4 clinical trials.
@ast
Radiation dosimetry results an ...... d data from 4 clinical trials.
@en
P2093
P1476
Radiation dosimetry results an ...... d data from 4 clinical trials.
@en
P2093
Bryan Leigh
Christine A White
Donald A Podoloff
Ellen Kornmehl
Gregory A Wiseman
Michael G Stabin
Richard B Sparks
Stewart Spies
Thomas Witzig
William D Erwin
P304
P407
P577
2003-03-01T00:00:00Z